Palliative care in end-stage liver disease: Time to do better?

Chiara Mazzarelli; Wendy M. Prentice; Michael A. Heneghan; Luca S. Belli; Kosh Agarwal; Mary D. Cannon

doi:10.1002/lt.25193

Palliative care in end-stage liver disease: Time to do better?

Chiara Mazzarelli, Wendy M. Prentice, Michael A. Heneghan, Luca S. Belli, Kosh Agarwal, Mary D. Cannon^*

^*Corresponding author for this work

King's College London

Research output: Contribution to journal › Review article › peer-review

43 Citations (Scopus)

Abstract

Optimal involvement of palliative care (PC) services in the management of patients with decompensated cirrhosis and end-stage liver disease (ESLD) is limited. This may result from both ignorance and the failure to recognize the spectrum and unpredictability of the underlying liver condition. Palliative care is a branch of medicine that focuses on quality of life (QoL) by optimizing symptom management and providing psychosocial, spiritual, and practical support for both patients and their caregivers. Historically, palliative care has been underutilized for patients with decompensated liver disease. This review provides an evidence-based analysis of the benefits of the integration of palliative care into the management of patients with ESLD. Liver Transplantation 24 961–968 2018 AASLD.

Original language	English
Pages (from-to)	961-968
Number of pages	8
Journal	Liver Transplantation
Volume	24
Issue number	7
DOIs	https://doi.org/10.1002/lt.25193
Publication status	Published - Jul 2018

Access to Document

10.1002/lt.25193

Cite this

@article{359593c495764cdb907685ce0adda2a6,

title = "Palliative care in end-stage liver disease: Time to do better?",

abstract = "Optimal involvement of palliative care (PC) services in the management of patients with decompensated cirrhosis and end-stage liver disease (ESLD) is limited. This may result from both ignorance and the failure to recognize the spectrum and unpredictability of the underlying liver condition. Palliative care is a branch of medicine that focuses on quality of life (QoL) by optimizing symptom management and providing psychosocial, spiritual, and practical support for both patients and their caregivers. Historically, palliative care has been underutilized for patients with decompensated liver disease. This review provides an evidence-based analysis of the benefits of the integration of palliative care into the management of patients with ESLD. Liver Transplantation 24 961–968 2018 AASLD.",

author = "Chiara Mazzarelli and Prentice, {Wendy M.} and Heneghan, {Michael A.} and Belli, {Luca S.} and Kosh Agarwal and Cannon, {Mary D.}",

year = "2018",

month = jul,

doi = "10.1002/lt.25193",

language = "English",

volume = "24",

pages = "961--968",

journal = "Liver Transplantation",

issn = "1527-6465",

publisher = "John Wiley and Sons Ltd",

number = "7",

}

TY - JOUR

T1 - Palliative care in end-stage liver disease

T2 - Time to do better?

AU - Mazzarelli, Chiara

AU - Prentice, Wendy M.

AU - Heneghan, Michael A.

AU - Belli, Luca S.

AU - Agarwal, Kosh

AU - Cannon, Mary D.

PY - 2018/7

Y1 - 2018/7

N2 - Optimal involvement of palliative care (PC) services in the management of patients with decompensated cirrhosis and end-stage liver disease (ESLD) is limited. This may result from both ignorance and the failure to recognize the spectrum and unpredictability of the underlying liver condition. Palliative care is a branch of medicine that focuses on quality of life (QoL) by optimizing symptom management and providing psychosocial, spiritual, and practical support for both patients and their caregivers. Historically, palliative care has been underutilized for patients with decompensated liver disease. This review provides an evidence-based analysis of the benefits of the integration of palliative care into the management of patients with ESLD. Liver Transplantation 24 961–968 2018 AASLD.

AB - Optimal involvement of palliative care (PC) services in the management of patients with decompensated cirrhosis and end-stage liver disease (ESLD) is limited. This may result from both ignorance and the failure to recognize the spectrum and unpredictability of the underlying liver condition. Palliative care is a branch of medicine that focuses on quality of life (QoL) by optimizing symptom management and providing psychosocial, spiritual, and practical support for both patients and their caregivers. Historically, palliative care has been underutilized for patients with decompensated liver disease. This review provides an evidence-based analysis of the benefits of the integration of palliative care into the management of patients with ESLD. Liver Transplantation 24 961–968 2018 AASLD.

UR - http://www.scopus.com/inward/record.url?scp=85050495482&partnerID=8YFLogxK

U2 - 10.1002/lt.25193

DO - 10.1002/lt.25193

M3 - Review article

C2 - 29729119

AN - SCOPUS:85050495482

SN - 1527-6465

VL - 24

SP - 961

EP - 968

JO - Liver Transplantation

JF - Liver Transplantation

IS - 7

ER -

Palliative care in end-stage liver disease: Time to do better?

Abstract

Access to Document

Other files and links

Fingerprint

Cite this